Webinar: Latest advances in treatment of ALL and what it means for patients ?
This webinar was made possible as a joint initiative between three LePAF networks (CLLAN, ALAN, and CMLAN) and the UK charity Leukaemia Care.
This educational webinar gave an overview of how ALL is treated today and the significance of ’hot topics’ and key treatment development advances published and discussed at 2022 international hematology conferences.
This webinar may be useful for people affected by a diagnosis of ALL: patients, family members, supporters and advocates.
What is new and what does this mean for patients?
Dr Tobias Menne, Consultant Hematologist, Clinical Director for Research, Honorary Senior Lecturer Newcastle University (UK)
Anne – Pierre Pickaert, Patient Advocate, Acute Leukemia Advocates Network (FR)
Sophie Wheldon, Patient Advocacy Officer, Leukaemia Care (UK)
2022 Treatment advances in ALL